Candida albicans biofilms and polymicrobial interactions

NO Ponde, L Lortal, G Ramage, JR Naglik… - Critical reviews in …, 2021 - Taylor & Francis
Candida albicans is a common fungus of the human microbiota. While generally a harmless
commensal in healthy individuals, several factors can lead to its overgrowth and cause a …

Candida albicans biofilm growth and dispersal: contributions to pathogenesis

G Wall, D Montelongo-Jauregui, BV Bonifacio… - Current opinion in …, 2019 - Elsevier
Highlights•Biofilm formation is a major contributor to pathogenesis during Candida
infection.•C. albicans biofilm formation is a multi-step, highly regulated process.•Cells in …

Recent insights into Candida albicans biofilm resistance mechanisms

L Mathé, P Van Dijck - Current genetics, 2013 - Springer
Like other microorganisms, free-living Candida albicans is mainly present in a three-
dimensional multicellular structure, which is called a biofilm, rather than in a planktonic form …

Candidemia: evolution of drug resistance and novel therapeutic approaches

AM Tortorano, A Prigitano, G Morroni… - Infection and Drug …, 2021 - Taylor & Francis
Candidemia and invasive candidiasis are the most common healthcare-associated invasive
fungal infections, with a crude mortality rate of 25–50%. Candida albicans remains the most …

Virulence factors in Candida species

M Staniszewska - Current Protein and Peptide Science, 2020 - ingentaconnect.com
Fungal diseases are severe and have very high morbidity as well as up to 60% mortality for
patients diagnosed with invasive fungal infection. In this review, in vitro and in vivo studies …

Contributions of the Biofilm Matrix to Candida Pathogenesis

JE Nett, DR Andes - Journal of Fungi, 2020 - mdpi.com
In healthcare settings, Candida spp. cause invasive disease with high mortality. The
overwhelming majority of cases are associated with the use of critically-needed medical …

Echinocandins in antifungal pharmacotherapy

A Patil, S Majumdar - Journal of Pharmacy and Pharmacology, 2017 - academic.oup.com
Objectives Echinocandins are the newest addition of the last decade to the antifungal
armamentarium, which, owing to their unique mechanism of action, selectively target the …

Osteoarticular mycoses

MN Gamaletsou, B Rammaert, B Brause… - Clinical Microbiology …, 2022 - Am Soc Microbiol
Osteoarticular mycoses are chronic debilitating infections that require extended courses of
antifungal therapy and may warrant expert surgical intervention. As there has been no …

Current perspectives on echinocandin class drugs

DS Perlin - Future microbiology, 2011 - Taylor & Francis
It has been nearly a decade since caspofungin was approved for clinical use as the first
echinocandin class antifungal agent, followed by micafungin and anidulafungin. The …

Candida survival strategies

M Polke, B Hube, ID Jacobsen - Advances in Applied Microbiology, 2015 - Elsevier
Only few Candida species, eg, Candida albicans, Candida glabrata, Candida dubliniensis,
and Candida parapsilosis, are successful colonizers of a human host. Under certain …